Cargando…
Update on alternative therapies for vulvovaginal atrophy
Although systemic absorption of estrogen with local treatment for vulvovaginal atrophy (VVA) is most likely to be negligible, it is unknown whether this minimal absorption will affect outcomes in women with breast cancer. Use of adjuvant therapy with aromatase inhibitors for breast cancer is associa...
Autor principal: | Chollet, Janet A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218114/ https://www.ncbi.nlm.nih.gov/pubmed/22114467 http://dx.doi.org/10.2147/PPA.S22943 |
Ejemplares similares
-
Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy
por: Parish, Sharon J, et al.
Publicado: (2013) -
Hormonal Approach for Postmenopausal Vulvovaginal Atrophy
por: Costa, Ana Paula Ferreira, et al.
Publicado: (2021) -
Use of Moisturizers and Lubricants for Vulvovaginal Atrophy
por: Sarmento, Ayane Cristine Alves, et al.
Publicado: (2021) -
Ospemifene: A Novel Option for the Treatment of Vulvovaginal Atrophy
por: Shin, Jae Jun, et al.
Publicado: (2017) -
New Innovations for the Treatment of Vulvovaginal Atrophy: An Up-to-Date Review
por: Benini, Vittoria, et al.
Publicado: (2022)